Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cardiac sarcoidosis].

Nils Milman1, Svend Aage Mortensen

  • 1Medicinsk Afdeling B2142, H:S Rigshospitalet, DK-2100 København Ø. milman@rh.dk

Ugeskrift for Laeger
|November 23, 2006
PubMed
Summary
This summary is machine-generated.

This review covers cardiac sarcoidosis, a condition affecting 5% of systemic sarcoidosis patients. Early diagnosis and treatment of cardiac sarcoidosis significantly improve patient outcomes and survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype.

Hepatology international·2018
Same author

Iron status in pregnant women and women of reproductive age in Europe.

The American journal of clinical nutrition·2017
Same author

Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).

Journal of perinatal medicine·2016
Same author

Supplementation during pregnancy: beliefs and science.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2016
Same author

[Post-partum iron deficiency anaemia].

Ugeskrift for laeger·2015
Same author

Coenzyme Q10: will this natural substance become a guideline-directed adjunctive therapy in heart failure?

JACC. Heart failure·2015

Area of Science:

  • Cardiology
  • Immunology
  • Pathology

Context:

  • Sarcoidosis is a multisystem inflammatory disease.
  • Cardiac involvement in sarcoidosis (cardiac sarcoidosis) affects approximately 30% of patients with systemic sarcoidosis.
  • Clinical manifestations of cardiac sarcoidosis are diverse and can be life-threatening.

Purpose:

  • To provide a comprehensive review of cardiac sarcoidosis.
  • To discuss the epidemiology, clinical manifestations, diagnosis, treatment, and prognosis of cardiac sarcoidosis.
  • To highlight the importance of adequate treatment for improving outcomes.

Summary:

  • Granulomas in the myocardium are found in about 30% of systemic sarcoidosis patients, with 5% exhibiting clinical cardiac signs.
  • Cardiac manifestations include pericarditis, heart block, arrhythmias, valvular disease, ventricular aneurysms, heart failure, and sudden cardiac death.

Related Experiment Videos

  • Sudden cardiac death and heart failure are the most common causes of mortality in cardiac sarcoidosis.

    • Impact:

    • Understanding the epidemiology and clinical spectrum of cardiac sarcoidosis is crucial for timely diagnosis.
    • Effective treatment strategies can significantly improve the prognosis and reduce mortality associated with cardiac sarcoidosis.
    • This review serves as a valuable resource for clinicians managing patients with cardiac sarcoidosis.